[English] 日本語
Yorodumi
- PDB-1pis: SOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1pis
TitleSOLUTION STRUCTURE OF PORCINE PANCREATIC PHOSPHOLIPASE A2
ComponentsPHOSPHOLIPASE A2
KeywordsCARBOXYLIC ESTER HYDROLASE / PHOSPHOLIPASE A2 / PHOSPHATIDE-2-ACYL-HYDROLASE / PLA2
Function / homology
Function and homology information


positive regulation of podocyte apoptotic process / regulation of glucose import / phosphatidylglycerol metabolic process / phosphatidylcholine metabolic process / phospholipase A2 activity / leukotriene biosynthetic process / neutrophil mediated immunity / calcium-dependent phospholipase A2 activity / phospholipase A2 / bile acid binding ...positive regulation of podocyte apoptotic process / regulation of glucose import / phosphatidylglycerol metabolic process / phosphatidylcholine metabolic process / phospholipase A2 activity / leukotriene biosynthetic process / neutrophil mediated immunity / calcium-dependent phospholipase A2 activity / phospholipase A2 / bile acid binding / positive regulation of calcium ion transport into cytosol / phospholipid metabolic process / lipid catabolic process / neutrophil chemotaxis / positive regulation of interleukin-8 production / positive regulation of MAP kinase activity / phospholipid binding / fatty acid biosynthetic process / cellular response to insulin stimulus / positive regulation of immune response / positive regulation of fibroblast proliferation / positive regulation of NF-kappaB transcription factor activity / intracellular signal transduction / signaling receptor binding / calcium ion binding / positive regulation of cell population proliferation / cell surface / positive regulation of transcription by RNA polymerase II / extracellular region
Similarity search - Function
Phospholipase A2, aspartic acid active site / Phospholipase A2 aspartic acid active site. / Phospholipase A2 / Phospholipase A2, histidine active site / Phospholipase A2 histidine active site. / Phospholipase A2 / Phospholipase A2 domain / Phospholipase A2 / Phospholipase A2 / Phospholipase A2 domain ...Phospholipase A2, aspartic acid active site / Phospholipase A2 aspartic acid active site. / Phospholipase A2 / Phospholipase A2, histidine active site / Phospholipase A2 histidine active site. / Phospholipase A2 / Phospholipase A2 domain / Phospholipase A2 / Phospholipase A2 / Phospholipase A2 domain / Phospholipase A2 domain superfamily / Up-down Bundle / Mainly Alpha
Similarity search - Domain/homology
Phospholipase A2, major isoenzyme
Similarity search - Component
Biological speciesSus scrofa (pig)
MethodSOLUTION NMR
AuthorsVan Den Berg, B.D. / Tessari, M. / De Haas, G.H. / Verheij, H.M. / Boelens, R. / Kaptein, R.
CitationJournal: EMBO J. / Year: 1995
Title: Solution structure of porcine pancreatic phospholipase A2.
Authors: van den Berg, B. / Tessari, M. / de Haas, G.H. / Verheij, H.M. / Boelens, R. / Kaptein, R.
History
DepositionDec 22, 1994Processing site: BNL
Revision 1.0Jun 3, 1995Provider: repository / Type: Initial release
Revision 1.1Mar 24, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance
Revision 1.3Feb 23, 2022Group: Database references / Derived calculations / Other
Category: database_2 / pdbx_database_status ...database_2 / pdbx_database_status / pdbx_struct_assembly / pdbx_struct_conn_angle / pdbx_struct_oper_list / struct_conn / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.process_site / _pdbx_struct_conn_angle.ptnr1_auth_comp_id / _pdbx_struct_conn_angle.ptnr1_auth_seq_id / _pdbx_struct_conn_angle.ptnr1_label_atom_id / _pdbx_struct_conn_angle.ptnr1_label_comp_id / _pdbx_struct_conn_angle.ptnr1_label_seq_id / _pdbx_struct_conn_angle.ptnr3_auth_comp_id / _pdbx_struct_conn_angle.ptnr3_auth_seq_id / _pdbx_struct_conn_angle.ptnr3_label_atom_id / _pdbx_struct_conn_angle.ptnr3_label_comp_id / _pdbx_struct_conn_angle.ptnr3_label_seq_id / _pdbx_struct_conn_angle.value / _struct_conn.pdbx_dist_value / _struct_conn.ptnr1_auth_comp_id / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_asym_id / _struct_conn.ptnr1_label_atom_id / _struct_conn.ptnr1_label_comp_id / _struct_conn.ptnr1_label_seq_id / _struct_conn.ptnr2_auth_comp_id / _struct_conn.ptnr2_auth_seq_id / _struct_conn.ptnr2_label_asym_id / _struct_conn.ptnr2_label_atom_id / _struct_conn.ptnr2_label_comp_id / _struct_conn.ptnr2_label_seq_id / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: PHOSPHOLIPASE A2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)14,0502
Polymers14,0101
Non-polymers401
Water00
1


  • Idetical with deposited unit
  • defined by author
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Atom site foot note1: GLN 4 - PHE 5 MODEL 1 OMEGA = 148.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: VAL 38 - ASP 39 MODEL 1 OMEGA = 146.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: LEU 41 - ASP 42 MODEL 1 OMEGA = 143.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: ASN 57 - LEU 58 MODEL 1 OMEGA = 216.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: LYS 62 - PHE 63 MODEL 1 OMEGA = 211.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: PHE 63 - LEU 64 MODEL 1 OMEGA = 138.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: CYS 77 - SER 78 MODEL 1 OMEGA = 130.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: ASN 79 - THR 80 MODEL 1 OMEGA = 89.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: ASN 85 - SER 86 MODEL 1 OMEGA = 217.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: SER 86 - LYS 87 MODEL 1 OMEGA = 148.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: LYS 87 - ASN 88 MODEL 1 OMEGA = 213.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: ALA 109 - PRO 110 MODEL 1 OMEGA = 149.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: LYS 113 - GLU 114 MODEL 1 OMEGA = 228.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: ASP 119 - THR 120 MODEL 1 OMEGA = 217.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: THR 120 - LYS 121 MODEL 1 OMEGA = 127.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: LYS 122 - TYR 123 MODEL 1 OMEGA = 211.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: PRO 37 - VAL 38 MODEL 2 OMEGA = 211.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: VAL 38 - ASP 39 MODEL 2 OMEGA = 140.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: LEU 41 - ASP 42 MODEL 2 OMEGA = 143.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: ASN 57 - LEU 58 MODEL 2 OMEGA = 225.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: PHE 63 - LEU 64 MODEL 2 OMEGA = 137.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: LEU 64 - VAL 65 MODEL 2 OMEGA = 122.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: CYS 77 - SER 78 MODEL 2 OMEGA = 133.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: ASN 79 - THR 80 MODEL 2 OMEGA = 121.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: ASN 85 - SER 86 MODEL 2 OMEGA = 213.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: ALA 109 - PRO 110 MODEL 2 OMEGA = 146.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: LYS 113 - GLU 114 MODEL 2 OMEGA = 228.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: LYS 116 - ASN 117 MODEL 2 OMEGA = 148.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: THR 120 - LYS 121 MODEL 2 OMEGA = 125.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: ALA 1 - LEU 2 MODEL 3 OMEGA = 126.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: LEU 2 - TRP 3 MODEL 3 OMEGA = 219.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: LYS 10 - CYS 11 MODEL 3 OMEGA = 139.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: VAL 38 - ASP 39 MODEL 3 OMEGA = 146.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: LEU 41 - ASP 42 MODEL 3 OMEGA = 140.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: ASN 57 - LEU 58 MODEL 3 OMEGA = 215.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: PHE 63 - LEU 64 MODEL 3 OMEGA = 131.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: CYS 77 - SER 78 MODEL 3 OMEGA = 119.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: ASN 79 - THR 80 MODEL 3 OMEGA = 120.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: LYS 113 - GLU 114 MODEL 3 OMEGA = 227.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: ASP 119 - THR 120 MODEL 3 OMEGA = 216.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: THR 120 - LYS 121 MODEL 3 OMEGA = 128.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: GLY 35 - THR 36 MODEL 4 OMEGA = 149.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: LEU 41 - ASP 42 MODEL 4 OMEGA = 142.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: ASN 57 - LEU 58 MODEL 4 OMEGA = 243.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: PHE 63 - LEU 64 MODEL 4 OMEGA = 148.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: LEU 64 - VAL 65 MODEL 4 OMEGA = 240.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: CYS 77 - SER 78 MODEL 4 OMEGA = 127.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: ASN 79 - THR 80 MODEL 4 OMEGA = 123.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: ASN 85 - SER 86 MODEL 4 OMEGA = 224.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
50: LYS 87 - ASN 88 MODEL 4 OMEGA = 214.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: LYS 113 - GLU 114 MODEL 4 OMEGA = 217.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: ASP 119 - THR 120 MODEL 4 OMEGA = 216.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: THR 120 - LYS 121 MODEL 4 OMEGA = 129.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: GLN 4 - PHE 5 MODEL 5 OMEGA = 135.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: ARG 6 - SER 7 MODEL 5 OMEGA = 147.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: VAL 38 - ASP 39 MODEL 5 OMEGA = 147.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: LEU 41 - ASP 42 MODEL 5 OMEGA = 143.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: ASN 57 - LEU 58 MODEL 5 OMEGA = 218.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: LEU 64 - VAL 65 MODEL 5 OMEGA = 282.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: CYS 77 - SER 78 MODEL 5 OMEGA = 129.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: ASN 79 - THR 80 MODEL 5 OMEGA = 113.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: ASN 85 - SER 86 MODEL 5 OMEGA = 224.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: SER 86 - LYS 87 MODEL 5 OMEGA = 148.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: LYS 87 - ASN 88 MODEL 5 OMEGA = 211.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: ALA 109 - PRO 110 MODEL 5 OMEGA = 149.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: LYS 113 - GLU 114 MODEL 5 OMEGA = 228.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ASP 119 - THR 120 MODEL 5 OMEGA = 213.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: THR 120 - LYS 121 MODEL 5 OMEGA = 125.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: ALA 1 - LEU 2 MODEL 6 OMEGA = 148.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: GLN 4 - PHE 5 MODEL 6 OMEGA = 145.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: GLY 35 - THR 36 MODEL 6 OMEGA = 148.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: LEU 41 - ASP 42 MODEL 6 OMEGA = 144.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: ASN 57 - LEU 58 MODEL 6 OMEGA = 213.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: PHE 63 - LEU 64 MODEL 6 OMEGA = 128.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: CYS 77 - SER 78 MODEL 6 OMEGA = 131.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: ASN 79 - THR 80 MODEL 6 OMEGA = 121.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: ASN 85 - SER 86 MODEL 6 OMEGA = 211.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: ALA 109 - PRO 110 MODEL 6 OMEGA = 144.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: LYS 113 - GLU 114 MODEL 6 OMEGA = 217.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: ASP 119 - THR 120 MODEL 6 OMEGA = 216.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: THR 120 - LYS 121 MODEL 6 OMEGA = 128.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: VAL 38 - ASP 39 MODEL 7 OMEGA = 149.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: LEU 41 - ASP 42 MODEL 7 OMEGA = 143.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: ASN 57 - LEU 58 MODEL 7 OMEGA = 224.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: PHE 63 - LEU 64 MODEL 7 OMEGA = 132.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: CYS 77 - SER 78 MODEL 7 OMEGA = 119.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: ASN 79 - THR 80 MODEL 7 OMEGA = 117.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: ASN 85 - SER 86 MODEL 7 OMEGA = 224.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: SER 86 - LYS 87 MODEL 7 OMEGA = 147.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: LYS 87 - ASN 88 MODEL 7 OMEGA = 213.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
91: ALA 109 - PRO 110 MODEL 7 OMEGA = 144.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: LYS 113 - GLU 114 MODEL 7 OMEGA = 218.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: ASP 119 - THR 120 MODEL 7 OMEGA = 216.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: THR 120 - LYS 121 MODEL 7 OMEGA = 140.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: LYS 121 - LYS 122 MODEL 7 OMEGA = 234.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: ALA 1 - LEU 2 MODEL 8 OMEGA = 126.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: LEU 2 - TRP 3 MODEL 8 OMEGA = 215.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: LYS 10 - CYS 11 MODEL 8 OMEGA = 139.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: VAL 38 - ASP 39 MODEL 8 OMEGA = 148.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: LEU 41 - ASP 42 MODEL 8 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: ASN 57 - LEU 58 MODEL 8 OMEGA = 236.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: PHE 63 - LEU 64 MODEL 8 OMEGA = 148.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: LEU 64 - VAL 65 MODEL 8 OMEGA = 235.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: CYS 77 - SER 78 MODEL 8 OMEGA = 123.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: ASN 79 - THR 80 MODEL 8 OMEGA = 125.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: ASN 85 - SER 86 MODEL 8 OMEGA = 227.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
107: SER 86 - LYS 87 MODEL 8 OMEGA = 146.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: LYS 113 - GLU 114 MODEL 8 OMEGA = 228.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: ASP 119 - THR 120 MODEL 8 OMEGA = 214.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: THR 120 - LYS 121 MODEL 8 OMEGA = 125.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: GLN 4 - PHE 5 MODEL 9 OMEGA = 137.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: ARG 6 - SER 7 MODEL 9 OMEGA = 142.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: THR 36 - PRO 37 MODEL 9 OMEGA = 141.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: VAL 38 - ASP 39 MODEL 9 OMEGA = 147.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: LEU 41 - ASP 42 MODEL 9 OMEGA = 142.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: ASN 57 - LEU 58 MODEL 9 OMEGA = 217.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: LEU 64 - VAL 65 MODEL 9 OMEGA = 118.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: CYS 77 - SER 78 MODEL 9 OMEGA = 130.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: ASN 79 - THR 80 MODEL 9 OMEGA = 90.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: ALA 109 - PRO 110 MODEL 9 OMEGA = 145.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: LYS 113 - GLU 114 MODEL 9 OMEGA = 216.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: ASN 117 - LEU 118 MODEL 9 OMEGA = 210.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: ASP 119 - THR 120 MODEL 9 OMEGA = 216.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: THR 120 - LYS 121 MODEL 9 OMEGA = 127.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: LYS 122 - TYR 123 MODEL 9 OMEGA = 211.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: VAL 38 - ASP 39 MODEL 10 OMEGA = 149.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: LEU 41 - ASP 42 MODEL 10 OMEGA = 143.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: ASN 57 - LEU 58 MODEL 10 OMEGA = 215.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: LYS 62 - PHE 63 MODEL 10 OMEGA = 210.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: PHE 63 - LEU 64 MODEL 10 OMEGA = 131.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: CYS 77 - SER 78 MODEL 10 OMEGA = 137.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: ASN 79 - THR 80 MODEL 10 OMEGA = 98.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: LYS 113 - GLU 114 MODEL 10 OMEGA = 224.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: ASP 119 - THR 120 MODEL 10 OMEGA = 213.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: THR 120 - LYS 121 MODEL 10 OMEGA = 124.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: LEU 2 - TRP 3 MODEL 11 OMEGA = 147.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: VAL 38 - ASP 39 MODEL 11 OMEGA = 149.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
138: LEU 41 - ASP 42 MODEL 11 OMEGA = 144.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
139: LYS 56 - ASN 57 MODEL 11 OMEGA = 149.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
140: ASN 57 - LEU 58 MODEL 11 OMEGA = 134.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
141: PHE 63 - LEU 64 MODEL 11 OMEGA = 128.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
142: CYS 77 - SER 78 MODEL 11 OMEGA = 132.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
143: ASN 79 - THR 80 MODEL 11 OMEGA = 120.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
144: ASN 85 - SER 86 MODEL 11 OMEGA = 211.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
145: ALA 109 - PRO 110 MODEL 11 OMEGA = 145.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
146: LYS 113 - GLU 114 MODEL 11 OMEGA = 217.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
147: ASN 117 - LEU 118 MODEL 11 OMEGA = 211.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
148: ASP 119 - THR 120 MODEL 11 OMEGA = 221.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
149: THR 120 - LYS 121 MODEL 11 OMEGA = 129.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
150: ALA 1 - LEU 2 MODEL 12 OMEGA = 253.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
151: LYS 10 - CYS 11 MODEL 12 OMEGA = 135.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
152: LEU 41 - ASP 42 MODEL 12 OMEGA = 144.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
153: ASN 57 - LEU 58 MODEL 12 OMEGA = 221.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
154: LEU 64 - VAL 65 MODEL 12 OMEGA = 234.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
155: CYS 77 - SER 78 MODEL 12 OMEGA = 127.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
156: ASN 79 - THR 80 MODEL 12 OMEGA = 118.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
157: ASN 85 - SER 86 MODEL 12 OMEGA = 218.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
158: ALA 109 - PRO 110 MODEL 12 OMEGA = 148.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
159: ASN 112 - LYS 113 MODEL 12 OMEGA = 147.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
160: ASN 117 - LEU 118 MODEL 12 OMEGA = 210.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
161: ASP 119 - THR 120 MODEL 12 OMEGA = 218.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
162: THR 120 - LYS 121 MODEL 12 OMEGA = 128.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
163: LYS 122 - TYR 123 MODEL 12 OMEGA = 211.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
164: GLN 4 - PHE 5 MODEL 13 OMEGA = 146.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
165: GLY 35 - THR 36 MODEL 13 OMEGA = 144.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
166: LEU 41 - ASP 42 MODEL 13 OMEGA = 141.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
167: ASN 57 - LEU 58 MODEL 13 OMEGA = 222.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
168: LEU 64 - VAL 65 MODEL 13 OMEGA = 235.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
169: CYS 77 - SER 78 MODEL 13 OMEGA = 132.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
170: ASN 79 - THR 80 MODEL 13 OMEGA = 80.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
171: ASN 85 - SER 86 MODEL 13 OMEGA = 217.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
172: ALA 109 - PRO 110 MODEL 13 OMEGA = 145.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
173: LYS 113 - GLU 114 MODEL 13 OMEGA = 228.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
174: LYS 116 - ASN 117 MODEL 13 OMEGA = 149.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
175: ASP 119 - THR 120 MODEL 13 OMEGA = 217.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
176: THR 120 - LYS 121 MODEL 13 OMEGA = 128.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
177: GLY 35 - THR 36 MODEL 14 OMEGA = 148.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
178: VAL 38 - ASP 39 MODEL 14 OMEGA = 148.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
179: LEU 41 - ASP 42 MODEL 14 OMEGA = 144.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
180: ASN 57 - LEU 58 MODEL 14 OMEGA = 214.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
181: PHE 63 - LEU 64 MODEL 14 OMEGA = 125.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
182: CYS 77 - SER 78 MODEL 14 OMEGA = 117.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
183: ASN 79 - THR 80 MODEL 14 OMEGA = 117.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
184: ASN 85 - SER 86 MODEL 14 OMEGA = 221.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
185: SER 86 - LYS 87 MODEL 14 OMEGA = 149.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
186: LYS 87 - ASN 88 MODEL 14 OMEGA = 213.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
187: ALA 109 - PRO 110 MODEL 14 OMEGA = 147.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
188: LYS 113 - GLU 114 MODEL 14 OMEGA = 225.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
189: ASP 119 - THR 120 MODEL 14 OMEGA = 214.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
190: THR 120 - LYS 121 MODEL 14 OMEGA = 140.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
191: LYS 121 - LYS 122 MODEL 14 OMEGA = 223.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
192: ALA 1 - LEU 2 MODEL 15 OMEGA = 117.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
193: LEU 2 - TRP 3 MODEL 15 OMEGA = 211.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
194: GLN 4 - PHE 5 MODEL 15 OMEGA = 140.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
195: ARG 6 - SER 7 MODEL 15 OMEGA = 140.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
196: LEU 41 - ASP 42 MODEL 15 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
197: ASN 57 - LEU 58 MODEL 15 OMEGA = 212.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
198: PHE 63 - LEU 64 MODEL 15 OMEGA = 126.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
199: CYS 77 - SER 78 MODEL 15 OMEGA = 121.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
200: ASN 79 - THR 80 MODEL 15 OMEGA = 115.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
201: ASN 85 - SER 86 MODEL 15 OMEGA = 222.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
202: LYS 87 - ASN 88 MODEL 15 OMEGA = 213.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
203: ALA 109 - PRO 110 MODEL 15 OMEGA = 145.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
204: LYS 113 - GLU 114 MODEL 15 OMEGA = 215.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
205: ASN 117 - LEU 118 MODEL 15 OMEGA = 210.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
206: ASP 119 - THR 120 MODEL 15 OMEGA = 216.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
207: THR 120 - LYS 121 MODEL 15 OMEGA = 129.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
208: GLY 35 - THR 36 MODEL 16 OMEGA = 148.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
209: LEU 41 - ASP 42 MODEL 16 OMEGA = 144.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
210: ASN 57 - LEU 58 MODEL 16 OMEGA = 214.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
211: PHE 63 - LEU 64 MODEL 16 OMEGA = 127.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
212: CYS 77 - SER 78 MODEL 16 OMEGA = 245.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
213: SER 78 - ASN 79 MODEL 16 OMEGA = 136.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
214: ASN 79 - THR 80 MODEL 16 OMEGA = 111.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
215: ASN 85 - SER 86 MODEL 16 OMEGA = 219.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
216: ALA 109 - PRO 110 MODEL 16 OMEGA = 148.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
217: LYS 113 - GLU 114 MODEL 16 OMEGA = 218.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
218: ASP 119 - THR 120 MODEL 16 OMEGA = 212.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
219: THR 120 - LYS 121 MODEL 16 OMEGA = 232.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
220: LYS 10 - CYS 11 MODEL 17 OMEGA = 148.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
221: GLY 35 - THR 36 MODEL 17 OMEGA = 146.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
222: VAL 38 - ASP 39 MODEL 17 OMEGA = 148.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
223: LEU 41 - ASP 42 MODEL 17 OMEGA = 143.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
224: CYS 45 - GLU 46 MODEL 17 OMEGA = 144.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
225: ASN 57 - LEU 58 MODEL 17 OMEGA = 217.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
226: PHE 63 - LEU 64 MODEL 17 OMEGA = 129.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
227: ASN 79 - THR 80 MODEL 17 OMEGA = 122.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
228: ASN 85 - SER 86 MODEL 17 OMEGA = 216.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
229: ALA 109 - PRO 110 MODEL 17 OMEGA = 146.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
230: LYS 113 - GLU 114 MODEL 17 OMEGA = 218.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
231: ASP 119 - THR 120 MODEL 17 OMEGA = 212.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
232: THR 120 - LYS 121 MODEL 17 OMEGA = 234.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
233: ARG 6 - SER 7 MODEL 18 OMEGA = 137.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
234: LEU 41 - ASP 42 MODEL 18 OMEGA = 142.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
235: ASN 57 - LEU 58 MODEL 18 OMEGA = 220.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
236: LEU 64 - VAL 65 MODEL 18 OMEGA = 115.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
237: CYS 77 - SER 78 MODEL 18 OMEGA = 114.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
238: ASN 79 - THR 80 MODEL 18 OMEGA = 119.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
239: ASN 85 - SER 86 MODEL 18 OMEGA = 216.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
240: ASN 101 - ALA 102 MODEL 18 OMEGA = 148.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
241: ASN 112 - LYS 113 MODEL 18 OMEGA = 148.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
242: LYS 116 - ASN 117 MODEL 18 OMEGA = 149.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
243: ASP 119 - THR 120 MODEL 18 OMEGA = 216.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
244: THR 120 - LYS 121 MODEL 18 OMEGA = 128.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
245: ALA 1 - LEU 2 MODEL 19 OMEGA = 126.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
246: LEU 2 - TRP 3 MODEL 19 OMEGA = 219.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
247: LYS 10 - CYS 11 MODEL 19 OMEGA = 143.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
248: VAL 38 - ASP 39 MODEL 19 OMEGA = 149.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
249: LEU 41 - ASP 42 MODEL 19 OMEGA = 140.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
250: ASN 57 - LEU 58 MODEL 19 OMEGA = 221.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
251: PHE 63 - LEU 64 MODEL 19 OMEGA = 131.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
252: CYS 77 - SER 78 MODEL 19 OMEGA = 127.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
253: ASN 79 - THR 80 MODEL 19 OMEGA = 119.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
254: ASN 85 - SER 86 MODEL 19 OMEGA = 211.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
255: ALA 109 - PRO 110 MODEL 19 OMEGA = 149.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
256: LYS 113 - GLU 114 MODEL 19 OMEGA = 218.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
257: ASP 119 - THR 120 MODEL 19 OMEGA = 220.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
258: THR 120 - LYS 121 MODEL 19 OMEGA = 127.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
259: LYS 122 - TYR 123 MODEL 19 OMEGA = 211.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
260: VAL 38 - ASP 39 MODEL 20 OMEGA = 149.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
261: LEU 41 - ASP 42 MODEL 20 OMEGA = 136.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
262: ASN 57 - LEU 58 MODEL 20 OMEGA = 223.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
263: PHE 63 - LEU 64 MODEL 20 OMEGA = 133.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
264: CYS 77 - SER 78 MODEL 20 OMEGA = 127.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
265: ASN 79 - THR 80 MODEL 20 OMEGA = 117.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
266: ASN 85 - SER 86 MODEL 20 OMEGA = 219.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
267: LYS 87 - ASN 88 MODEL 20 OMEGA = 223.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
268: ALA 109 - PRO 110 MODEL 20 OMEGA = 145.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
269: ASN 112 - LYS 113 MODEL 20 OMEGA = 149.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
270: ASP 119 - THR 120 MODEL 20 OMEGA = 216.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
271: THR 120 - LYS 121 MODEL 20 OMEGA = 128.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR ensembles
DataCriteria
Number of conformers (submitted / calculated)20 / -
Representative

-
Components

#1: Protein PHOSPHOLIPASE A2


Mass: 14009.714 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Sus scrofa (pig) / Organ: PANCREAS / References: UniProt: P00592, phospholipase A2
#2: Chemical ChemComp-CA / CALCIUM ION


Mass: 40.078 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Ca

-
Experimental details

-
Experiment

ExperimentMethod: SOLUTION NMR

-
Sample preparation

Crystal grow
*PLUS
Method: other

-
Processing

NMR ensembleConformers submitted total number: 20

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more